CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort
about
Antiretroviral therapy response among HIV-2 infected patients: a systematic reviewTransmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg databaseFirst-year lymphocyte T CD4+ response to antiretroviral therapy according to the HIV type in the IeDEA West Africa collaborationGenotypic resistance profiles of HIV-2-treated patients in West Africa.Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource SettingsCharacteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.HIV-2 goes global: an unaddressed issue in Indian anti-retroviral programmes.Characteristics, immunological response & treatment outcomes of HIV-2 compared with HIV-1 & dual infections (HIV 1/2) in MumbaiUpdate on human immunodeficiency virus (HIV)-2 infection.HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.Human immunodeficiency virus type 2 in two Saudi families.Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors.Immunologic response in treatment-naïve HIV-2-infected patients: the IeDEA West Africa cohort.Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West AfricaA call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa.Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.Special aspects of the treatment of HIV-2-infected patients.Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.Mortality and survival patterns of people living with HIV-2Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso.Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man
P2860
Q27003854-8D2A9568-F577-496E-B374-51BC50F930D8Q33321434-E85A3DD7-FADE-4A0F-9217-F15E308B99B7Q33891896-847F47DA-7C0C-4952-B9B4-D021C9B7C99AQ33954546-3E2CAF20-060C-4BDA-BB71-560ADE96C166Q34730950-19BFB8D4-1E34-41EC-9917-F9820E32CCC6Q34793224-1D4CA29E-284B-4A3C-9FCC-5C1CE186D69EQ35008562-4753EC50-04A1-4DFF-B74A-CB185DACB360Q35008574-3C3E7AA0-52F3-4FDC-B83E-893827F39944Q35019924-02C3C229-4279-464F-8C91-141AB97203C6Q35134947-998105C7-C92F-4567-9849-CF64A104C085Q35165841-57D1ACDD-5613-4AF0-83A5-D1EADC3754CCQ35674666-9E7F8570-0F7C-4647-8D2B-49ADAC375C20Q36538702-95DC76F4-163F-4560-945D-08334D910B48Q36564668-D9EDAFF0-16FF-4E82-9BAE-8ECAE2970ACBQ36897863-90A505DC-9FFB-4EBA-B4D3-F6BE4BD1A5BBQ37083896-5FADED3E-2296-4100-89C1-4875AA19CB28Q37307096-35A25FE3-517F-4909-B5F9-A7DA8AF53973Q37979706-053B74B8-E68F-463E-BFC5-BD42A6C8F8FDQ38538043-CA43D065-7DB2-48BE-BB28-8E34E8F59102Q38851677-EBCBAA0C-6C27-46B8-8054-D498F4F6ED49Q39902009-E06785BC-FB54-4915-97DE-2DA45C4F06A3Q44990505-64F61F92-B3F7-4D65-8F08-BE09976F29A0Q52625498-B989540A-7DEE-42DE-A8A7-1ACB707DFB21Q57493693-7BD34F06-A6EA-43FE-8516-73829CD2D9BC
P2860
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort
description
article
@en
im Februar 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2006
@uk
name
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@en
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@nl
type
label
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@en
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@nl
prefLabel
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@en
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@nl
P2093
P50
P1433
P1476
CD4 cell recovery in treated H ...... e French ANRS CO5 HIV-2 cohort
@en
P2093
Antoine Benard
Audrey Taieb
Francoise Brun-Vezinet
Pauline Campa
Sophie Pueyo
P304
P356
10.1097/01.AIDS.0000199829.57112.2F
P407
P577
2006-02-01T00:00:00Z